UPDATED Jul 25, 2024
Discover Norwegian Pharmaceuticals & Biotech Growth Stocks that are on the OSEAX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CRNA | NOK 2.16 | -3.6% | -87.5% | NOK 23.0m | NOK 3.00 | PS187.1x | E97.8% | n/a | ||
PHO | NOK 54.20 | -3.4% | 16.2% | NOK 1.5b | NOK 86.00 | PE304.7x | E92.4% | 0% | ||
AZT | NOK 24.30 | 0.4% | -38.0% | NOK 1.2b | NOK 27.50 | PE70.7x | E48.1% | n/a | ||
NAVA | NOK 33.00 | 0.3% | -9.8% | NOK 575.3m | NOK 46.50 | PS1.1x | E38.9% | n/a | ||
ULTI | NOK 7.90 | 3.9% | -89.8% | NOK 271.8m | NOK 6.50 | PB1x | E28.5% | n/a | ||
ABS | NOK 10.20 | -1.9% | -1.4% | NOK 258.8m | NOK 10.00 | PS7.7x | E-6.0% | n/a | ||
NYKD | NOK 14.00 | -3.9% | -52.3% | NOK 4.6b | NOK 36.63 | PS37.3x | E-17.8% | n/a | ||
BGBIO | NOK 12.85 | -0.4% | 18.8% | NOK 502.3m | NOK 30.67 | PS964x | E-24.9% | n/a | ||
NANOV | NOK 2.00 | -18.3% | -22.2% | NOK 231.8m | n/a | PB3.6x | n/a | n/a | ||
SOFTX | NOK 0.069 | -19.2% | -99.1% | NOK 35.6m | n/a | PE-0.6x | n/a | n/a | ||
EXTX | NOK 7.15 | -10.1% | -37.8% | NOK 229.4m | n/a | PS51452.7x | n/a | n/a | ||
VISTN | NOK 21.20 | 0% | -11.7% | NOK 940.1m | n/a | PE16.7x | n/a | 4.7% | ||
NORD | NOK 41.00 | 0% | n/a | NOK 203.8m | n/a | n/a | n/a | 0% | ||
PCIB | NOK 1.78 | -1.0% | -7.9% | NOK 66.5m | n/a | PS22.2x | n/a | n/a | ||
HBC | NOK 2.03 | -4.2% | -32.3% | NOK 802.0m | n/a | PS3.5x | n/a | n/a | ||
LYTIX | NOK 9.00 | 0.7% | 32.4% | NOK 446.5m | NOK 13.00 | PS30.8x | S110.7% | n/a | ||
TRMED | NOK 1.03 | -0.8% | -43.1% | NOK 241.0m | n/a | PB0.9x | n/a | n/a |